Fatal thrombosis after administration of activated prothrombin complex concentrates in a patient supported by extracorporeal membrane oxygenation who had received activated recombinant factor VII.
D001779:Blood Coagulation Factors / Q000009:adverse effects*; D001989:Bronchiolitis Obliterans / Q000601:surgery; D002315:Cardiopulmonary Bypass; D015199:Extracorporeal Membrane Oxygenation; D005167:Factor VII / Q000009:adverse effects* / Q000627:therapeutic use; D015942:Factor VIIa; D017809:Fatal Outcome; D006488:Hemostasis, Surgical / Q000379:methods*; D006801:Humans; D016040:Lung Transplantation; D008297:Male; D008875:Middle Aged; D029424:Pulmonary Disease, Chronic Obstructive / Q000601:surgery; D011994:Recombinant Proteins / Q000009:adverse effects* / Q000627:therapeutic use; D013927:Thrombosis / Q000209:etiology*
D001779:Blood Coagulation Factors; D011994:Recombinant Proteins; C025667:prothrombin complex concentrates; D005167:Factor VII; C103587:recombinant FVIIa; D015942:Factor VIIa